Syner-G Appoints Industry Veteran Chris Erickson as COO
Portfolio - People | Mar 04, 2025 | EIN
Syner-G BioPharma Group and Sequoia Biotech Consulting have appointed experienced industry leader Chris Erickson as their new Chief Operating Officer. With over 25 years in the pharmaceutical services industry, Erickson brings a wealth of expertise in scaling global operations, enhancing commercial strategies, and driving customer-centric growth. He has previously held significant roles at Cytel and PAREXEL, contributing to substantial company growth and successful acquisition integrations. Erickson's appointment comes as Syner-G and Sequoia, which merged in September 2024, aim to further enhance their operational efficiencies and deliver exceptional value to clients. The company specializes in consulting and regulatory services, focusing on product development, regulatory strategy, and commercial manufacturing.
Sectors
- Life Sciences
- Biotechnology
- Pharmaceutical Services
Geography
- United States – Syner-G BioPharma Group and Sequoia Biotech Consulting are based in Boston, U.S., and the appointment is relevant to the U.S. pharmaceutical and biotech sectors.
Industry
- Life Sciences – The article details the appointment of a new COO at a leading life sciences consulting and regulatory services firm.
- Biotechnology – The merging companies, Syner-G BioPharma and Sequoia Biotech, operate within the biotechnology sector, providing regulatory and consulting services.
- Pharmaceutical Services – The background and expertise of the appointed COO, Chris Erickson, are in pharmaceutical services, highlighting the industry's relevance to the article.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Syner-G BioPharma Group | Target Company | Company | A premier life sciences consulting and regulatory services firm. |
| Sequoia Biotech Consulting | Target Company | Company | A leading provider of integrated life science services. |
| Chris Erickson | New COO | Person | An industry veteran with over 25 years of experience, recently appointed as Chief Operating Officer. |
| Ron Kraus | CEO | Person | CEO of Syner-G BioPharma Group & Sequoia Biotech Consulting. |